Cargando…
Glycoproteomic analysis of two mouse mammary cell lines during transforming growth factor (TGF)-β induced epithelial to mesenchymal transition
BACKGROUND: TGF-β acts as an antiproliferative factor in normal epithelial cells and at early stages of oncogenesis. However, later in tumor development TGF-β can become tumor promoting through mechanisms including the induction of epithelial-to-mesenchymal transition (EMT), a process that is though...
Autores principales: | Hill, Jennifer J, Tremblay, Tammy-Lynn, Cantin, Christiane, O'Connor-McCourt, Maureen, Kelly, John F, Lenferink, Anne EG |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651118/ https://www.ncbi.nlm.nih.gov/pubmed/19128513 http://dx.doi.org/10.1186/1477-5956-7-2 |
Ejemplares similares
-
Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-β and Neu pathway signaling studies: identification of a novel model for TGF-β-induced epithelial-to-mesenchymal transition
por: Lenferink, Anne EG, et al.
Publicado: (2004) -
Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker
por: Aguilar-Mahecha, Adriana, et al.
Publicado: (2009) -
Identification of high-quality cancer prognostic markers and metastasis
network modules
por: Li, Jie, et al.
Publicado: (2010) -
Corrigendum: Identification of high-quality cancer prognostic markers and metastasis
network modules
por: Li, Jie, et al.
Publicado: (2012) -
Stromal and epithelial TGF-β signaling in mammary tumorigenesis
por: Moses, HL, et al.
Publicado: (2005)